生物学评价报告怎么写才算完整

结论：评价报告是论证文件，不是试验报告的封面

很多企业提交的所谓「生物学评价报告」，实际上是几份试验报告装订在一起，前面加一页说明。这不是评价，这是汇总。

评价报告要回答的问题是：这个产品在预期使用条件下，生物学风险是否可接受，依据是什么。 试验结果只是依据之一，不是全部，也不能自动得出结论。

所以报告的核心是论证过程——从产品信息出发，识别风险，确定需要什么证据，收集证据，解释证据，得出结论。缺了论证，试验做得再多也不构成评价。

报告应当包含的要素

「缺口分析」是最能体现评价质量的部分。 它说明为什么做这些试验、为什么不做那些试验。没有缺口分析，试验项目的选择就没有依据，多做少做都无从判断。

接触判定的依据

接触性质与接触时间决定了需要考虑哪些生物学终点，所以这个判定要有明确依据，而不是凭印象。

接触性质。 是与完好皮肤接触、与黏膜接触、与破损组织接触、还是与血液接触。同一个产品的不同部件可能不同，要分别判定。

接触时间。 单次接触时长、累计接触时长。要按实际使用方式估算，而不是按最保守或最宽松的假设。

间接接触也要考虑。 流体通路上的材料虽然不直接接触人体，但流体经过后进入人体，同样需要评价。

判定要写出理由。 比如「本产品用于长期卧床使用者，每日接触时间约多少小时，累计超过某个界限，因此按长期接触考虑」。这样写，审查方能看懂判断过程。

材料信息的收集

这是实务中最费力的环节，因为信息往往在供应商手里。需要收集的包括：

材料的化学名称与牌号；添加剂信息（增塑剂、稳定剂、着色剂、阻燃剂）；加工过程中使用的助剂（脱模剂、润滑剂、清洗剂）；表面处理的材料；以及粘接剂、油墨、标签材料。

容易遗漏的是「非主体材料」 ——油墨、标签胶、密封圈、螺纹胶。这些用量小但可能是风险来源。

建议建立一份完整的材料清单，按部件逐项列出，并标注每种材料是否与人体接触、接触方式如何。这份清单是后续所有工作的基础。

已有数据的利用

不是所有终点都需要做试验。可以利用的已有数据包括：

材料的使用历史。 同样的材料在同样的接触条件下已有长期安全使用记录。

文献数据。 公开的毒理学数据。

供应商数据。 材料供应商提供的评价资料。

同类产品的数据。 在能论证等同性的前提下。

利用已有数据需要论证适用性 ——材料是否真的相同（牌号、供应商、加工方式）、接触条件是否可比、数据是否可靠。论证不充分的引用，审查时会被质疑。

试验结果的解释

有了结果不等于有了结论。解释时要注意：

阴性结果说明什么。 在该试验条件下未观察到相应效应，不等于绝对安全。

阳性或可疑结果怎么处理。 不能简单归为「试验误差」。要分析原因——是材料本身、是加工残留、还是试验方法的影响。必要时做进一步试验。

结果与预期使用的关联。 试验条件与实际使用条件的差异要说明。

综合判断。 各项结果放在一起，结合材料信息和使用条件，得出整体结论。

常见的不完整表现

只有试验报告没有论证。 前面说过，这是最常见的。

材料清单不全。 漏掉油墨、粘接剂之类。

接触判定无依据。 直接写「短期接触」而不说为什么。

试验项目选择无理由。 做了三项，但没说为什么是这三项。

试样不是最终状态。 用原材料或半成品做试验，而不是经过全部加工和灭菌的成品。

变更后未重新评价。 材料、供应商、加工工艺变更后，原评价可能不再适用。

评价人员资质未说明。 评价需要由具备相应知识的人员完成。

变更时的处理

评价结论是基于某个时点的产品状态。以下变更应当触发重新评价：

材料牌号或供应商变更；加工工艺变更（含清洗、灭菌方式）；接触部位或接触时间变更；表面处理变更；以及预期用途扩展。

「同类替代」不能免除评价。 换一个牌号的同类材料，添加剂配方可能完全不同。建议把生物学评价的复核纳入变更评审的固定环节。

试验项目的选择逻辑

缺口分析做完之后，试验项目的选择就有了依据。选择时的基本逻辑是：

先看哪些终点需要考虑。 由接触性质和接触时间决定。

再看每个终点是否已有充分数据。 有的话不必做试验。

没有的才设计试验。 并且优先考虑能否用化学表征加毒理学评估的路径替代部分动物试验。

试验方法的选择要匹配产品特性。 比如产品形状不规则、材料难以浸提，方法要相应调整。

这个逻辑写在报告里，就是评价的论证主线。 审查方看的是这条线是否成立，而不是试验做了几项。

报告的可读性

评价报告是给人看的，结构清楚能减少很多沟通成本。建议：

结论前置。 开头就说清楚结论是什么。

论证过程可追溯。 每个判断都能找到依据。

表格化呈现。 材料清单、终点与数据的对应关系用表格，比大段文字清楚。

附件编号清晰。 试验报告作为附件，正文引用时编号对应。

版本与日期明确。 评价是有时效的，版本信息要清楚。

我们的做法

承接生物学相关委托时，我们会先要求提供完整的材料清单和加工信息，再据此讨论试验项目。没有材料信息就定试验项目，是把顺序做反了 ——可能做了不必要的项目，也可能漏掉关键项目。

试样方面，我们要求提供最终状态的成品，经过全部加工和灭菌。用半成品做出来的数据，不能代表实际产品。

如果你在准备生物学评价，不确定需要做哪些项目，可以把材料清单和产品使用方式发过来一起讨论，或者直接联系：132 4819 8029。能力范围见服务介绍，送检要求见送检要求，流程见检测流程。

English version

Conclusion. Many so-called biological evaluation reports are several test reports bound together behind a covering page. That is a compilation, not an evaluation. An evaluation report must answer whether the biological risk of the product under its intended conditions of use is acceptable, and on what basis. Test results are one form of evidence, not the whole of it, and they do not yield a conclusion by themselves. The core of the report is therefore the reasoning: starting from product information, identifying risks, determining what evidence is needed, gathering it, interpreting it and reaching a conclusion. Without that reasoning, no amount of testing constitutes an evaluation.

Elements the report should contain. A product description covering intended use, manner of use and contacting parts. A contact determination with the basis for the nature and duration of contact. Material information listing every directly and indirectly contacting material. Manufacturing information covering processing aids, cleaning and sterilisation and what they may introduce. Existing data covering history of use, literature and prior testing. A gap analysis identifying what existing data do not cover. A test plan designed to fill those gaps. Results and their interpretation. A conclusion on acceptability of risk. And the qualifications of the evaluator. The gap analysis is what best reveals the quality of an evaluation, because it explains why these tests were done and those were not. Without it, the selection of test items has no basis and there is no way to judge whether too much or too little was done.

Basis for the contact determination. The nature and duration of contact determine which biological endpoints must be considered, so the determination needs an explicit basis rather than an impression. On nature: whether contact is with intact skin, mucosal membrane, breached tissue or blood, determined separately for each part where they differ. On duration: single-exposure and cumulative contact time, estimated from actual use rather than the most conservative or most permissive assumption. Indirect contact must also be considered, since materials in a fluid path do not touch the body while the fluid that passes them does. Write out the reasoning, for instance that the product serves users confined to bed, contact lasts approximately so many hours daily, cumulative exposure exceeds a given threshold, and prolonged contact is therefore assumed. Written that way, a reviewer can follow the judgement.

Gathering material information. This is the most laborious part in practice, because the information sits with suppliers. Collect chemical names and grades; additive information covering plasticisers, stabilisers, colourants and flame retardants; processing aids such as release agents, lubricants and cleaning agents; surface treatment materials; and adhesives, inks and label materials. Non-structural materials are the ones most often missed, including inks, label adhesives, sealing rings and thread-locking compounds, which are used in small quantities yet can be sources of risk. Build a complete material list part by part, marking whether each material contacts the body and how. That list underpins everything that follows.

Using existing data. Not every endpoint requires testing. Usable existing data include history of use, where the same material has a long safe record under the same contact conditions; literature toxicological data; supplier evaluation data; and data on similar products, where equivalence can be argued. Using existing data requires justifying its applicability: whether the material is genuinely the same in grade, supplier and processing, whether contact conditions are comparable, and whether the data are reliable. Poorly justified citation invites challenge during review.

Interpreting results. Having results is not having a conclusion. A negative result means no corresponding effect was observed under those test conditions, which is not the same as absolute safety. A positive or equivocal result cannot simply be dismissed as experimental error; analyse the cause, whether the material itself, processing residues or the method, and test further if needed. Differences between test conditions and actual use must be explained. And the results must be considered together, alongside material information and conditions of use, to reach an overall conclusion.

Common signs of incompleteness. Test reports without reasoning, which is the most frequent. Incomplete material lists that omit inks or adhesives. Contact determinations with no stated basis, simply asserting short-term contact. Test selection without justification, three items performed with no explanation of why those three. Specimens that are not in final condition, using raw or semi-finished material rather than fully processed and sterilised product. No re-evaluation after change, where material, supplier or process has changed and the original evaluation may no longer hold. And no statement of evaluator qualification, when evaluation requires appropriately knowledgeable personnel.

Handling changes. A conclusion rests on the product as it was at a point in time. The following should trigger re-evaluation: a change of material grade or supplier; a process change including cleaning or sterilisation method; a change in contacting part or contact duration; a change of surface treatment; and any extension of intended use. Like-for-like substitution does not remove the need: another grade of the same material type may carry an entirely different additive package. Build a biological evaluation check into the standing change review.

How we handle it. For biological work we ask for a complete material list and processing information before discussing test items. Setting test items without material information reverses the proper order and risks both unnecessary items and missed critical ones. For specimens we require final-condition product that has been through all processing and sterilisation, since data from semi-finished parts do not represent the actual product.

Send us the material list and how the product is used and we will discuss what is needed. Phone or WeChat: +86 132 4819 8029.